Custom Cardiac PET/CT Suite Solutions

Delivered straight to your practice

Partner with CDL Nuclear Technologies, the #1 provider of affordable, end-to-end Cardiac PET MPI in the US and trusted by more cardiologists.

Watch Video Take Tour

CDL: Your Preferred Partner
For Cardiac PET/CT

From Start...
180 Days
In just 180 days,* we’ll take you from PLANNING to SCANNING *On average
...To Finish

Exclusive 200-point process: the most comprehensive service and support available

  • Suite planning (including assessment/consultation) & construction
  • Equipment acquisition at preferred pricing
  • Physician/staff training by nationally recognized experts
  • Accreditation processes
  • Customized patient resources
  • Billing assistance
  • Risk management strategies
  • Maintenance and repairs

CDL: A Highly Experienced & Dedicated Partner

The leading provider of Cardiac PET and PET/CT solutions in the US

Founded in 1992
Partnering with medical practices for 30 years

Offering unmatched affordability
to make advanced Cardiac PET and PET/CT accessible

Reimbursement coverage
and payment relationship network (political and societal advocacy)

Watch Video

Custom Cardiac PET/CT Suite Solutions

Tours

video cover

Cardiac PET/CT Suite Virtual Tour #1

Enjoy a virtual tour of our PET/CT suite with a Siemens Horizon camera.

video cover

Cardiac PET/CT Suite Virtual Tour #2

Enjoy a virtual tour of our PET/CT suite with a GE Omni camera.

Benefits of Cardiac PET1

  • High diagnostic accuracy
  • Consistent high-quality images
  • Low radiation exposure
  • Short acquisition protocols
  • Quantification of myocardial blood flow
  • Strong prognostic power

Numbers that tell the difference

  SPECT PET
Study time2 and pharmacologic stress duration 3-5 hrs 20-30 mins
Sensitivity3
(50% coronary stenosis threshold)		 81% 86%
Specificity3
(50% coronary stenosis threshold)		 66% 100%
Accuracy3
(50% coronary stenosis threshold)		 76% 91%
Patient radiation exposure3 0.667 rads / 6.67 mSv .30 rads / 3 mSv
References:
  1. Bateman TM et al. J Nucl Cardiol. 2016;23: 1227-1231
  2. Bateman TM. J Nucl Cardiol. 2012;19: 3-11
  3. Bateman TM et al. J Nucl Cardiol. 2006;13: 24-33

Society Support for Cardiac PET

ASNC/SNMMI

PET MPI has been shown to be the most accurate noninvasive test for assessment of suspected or known CAD. Other notable cardiac PET applications include inflammation imaging, infection assessment and viability assessment. These applications are helpful to the general cardiology community and for managing complex cases that often require multimodality imaging,"
—Dr. Mouaz Al-Mallah, ASNC President
  • ASNC

Position Statement:

American Society of Nuclear Cardiology recommends that PET MPI, if available, be the preferred modality for all patients who meet criteria for MPI. There are no clinical scenarios or patient subgroups in which the use of PET MPI should be excluded, given its diagnostic accuracy, risk stratification, and unique quantitative capabilities.

ACC/AHA

  • ACC
Class Of Recommendation   Level Of Evidence   Stress Testing
Class 1 (Strong) Level B-NR For intermediate-risk patients with acute chest pain and no known CAD who are eligible for cardiac testing, either exercise ECG, stress echocardiography, stress PET/SPECT MPI, or stress CMR is useful for the diagnosis of myocardial ischemia